# Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.

> **NCT03807973** · PHASE1 · SUSPENDED · sponsor: **University of Alabama at Birmingham** · enrollment: 120 (estimated)

## Conditions studied

- Fibromyalgia
- Chronic Fatigue Syndrome
- Multiple Sclerosis
- Healthy

## Interventions

- **DRUG:** [Zr-89]Oxine-labeled leukocytes PET/MRI

## Key facts

- **NCT ID:** NCT03807973
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-10-05
- **Primary completion:** 2028-10
- **Final completion:** 2028-10
- **Target enrollment:** 120 (ESTIMATED)
- **Why stopped:** Lost funding.
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03807973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03807973, "Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03807973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*